Ticarcillin clavulanate potassium (Timentin)

By attaching to one or more of the penicillin-binding proteins, ticarcillin clavulanate potassium prevents the formation of bacterial cell walls (PBPs).

Ttreats the following infections:

  • Bone and joint infections occurs due to:

    • beta-lactamase-producing isolates of Staphylococcus aureus.

  • Endometritis caused by:

    • Beta-lactamase-producing isolates of Prevotella melaninogenicus,

    • Enterobacter species (including E. cloacae)

    • S. aureus

    • Klebsiella pneumoniae

    • Escherichia coli or

    • Staphylococcus epidermidis.

  • Lower respiratory tract infections caused by:

    • Beta-lactamase-producing isolates of S. aureus

    • Haemophilus influenzae

    • Klebsiella species.

  • Peritonitis occurs due to:

    • Beta-lactamase-producing isolates of E. coli,

    • K. pneumonia

    • Bacteroides fragilis group.

  • Septicemia including bacteremia caused by:

    • Beta-lactamase-producing isolates of Klebsiella species

    • E. coli

    • S. aureus

    • Pseudomonas aeruginosa (or other Pseudomonas species).

  • Skin and skin structure infections occurs due to:

    • beta-lactamase-producing isolates of S. aureus

    • Klebsiella species

    • E. coli.

  • Complicated and uncomplicated Urinary tract infections occurs due to:

    • beta-lactamase-producing isolates of E. coli

    • Klebsiella species

    • P. aeruginosa (and other Pseudomonas species)

    • S. aureus

    • Citrobacter species

    • Enterobacter cloacae

    • Serratia marcescens

  • Off Label Usage of Ticarcillin clavulanate potassium in Adults:

    • Intra-abdominal infections

    • Cystic fibrosis exacerbations

Ticarcillin clavulanate dose in Adults

  • Ticarcillin clavulanate is a combination product
  • Each 3.1 g dosage form contains 3 g ticarcillin disodium and 0.1 g clavulanic acid.

Dosage in the treatment of Gynecologic infections like endometritis:

  • Moderate infections:

    • The maximum daily dose is 12 g of ticarcillin given intravenously in divided doses every 6 hours.
  • Severe infections:

    • Every 4 hours, 300 mg/kg of ticarcillin is administered intravenously in divided doses.
    • The daily maximum dose is 18 g.

Systemic infections:

  • <60 kg:

    • Divided doses of 200-300 mg/kg/day of ticarcillin are administered intravenously every 4–6 hours.
    • The daily maximum dose is 18 g.
  • ≥60 kg:

    • 1 gm intravenously is given every 4-6 hours

Dosage in the treatment of Urinary tract infections:

  • <60 kg:

    • Divided doses of 200-300 mg/kg/day of ticarcillin are administered intravenously every 4–6 hours.
    • The daily maximum dose is 18 g.
  • ≥60 kg:

    • 1 gm intravenously is given every 4-6 hours

Off label Dosage for treating complicated mild to moderate community-acquired Intra-abdominal infection:

  • 3.1 g is given every 6 hours for 4-7 days

Ticarcillin clavulanate dose in Children

General dosing for susceptible infection:

  • Infants, Children, and Adolescents:
    • Mild to moderate infections:

      • Divided dosages of 200 mg/kg/day of ticarcillin are administered intravenously every six hours.
      • The daily dose cap is 12 g of ticarcillin.
    • Severe infections:

      • Manufacturer's labeling:
      • Split dosages of 300 mg/kg/day of ticarcillin are administered intravenously every four hours.
    • AAP recommendations:

      • Divided doses of 200-300 mg/kg/day of ticarcillin are administered intravenously every 4–6 hours.
      • The daily dose cap is 18 g of ticarcillin.

Dose in the treatment of Cystic fibrosis:

  • Infants, Children, and Adolescents:
    • Higher doses have also been utilised, such as: 400 mg ticarcillin/kg/day intravenously administered in divided doses every 6 hours. split dosages of 400–750 mg of ticarcillin per kilogramme every six hours.

Ticarcillin clavulanate Pregnancy Risk Factor B

  • Animal reproduction studies did not show any adverse events.
  • Placenta can be crossed by Ticarcillin or Clavulanate
  • Penicillin use by mothers has not been associated with an increase in the risk of side effects for fetus.
  • For the treatment of postpartum gynecologic infections, including endometritis, brought on by susceptible microorganisms, ticarcillin/clavulanate is recommended.

Ticarcillin clavulanate potassium use during breastfeeding:

  • Breast milk contains small amounts of ticarcillin, but it is not absorbed if taken orally.
  • The manufacturer suggests that nursing mothers exercise caution when administering ticarcillinclavulanate.

Ticarcillin clavulanate dose in Renal disease:

  • Loading dose:
    • 3.1 gms intravenously as a single dose, followed by maintenance dose according to creatinine clearance:
      • CrCl 30-60 mL/minute:

        • Give 2 g of ticarcillin component every 4 hours
      • CrCl 10-30 mL/minute:

        • Give 2 g of ticarcillin component every 8 hours
      • CrCl <10 mL/minute:

        • Give 2 g of ticarcillin component every 12 hours
      • CrCl <10 mL/minute with concomitant hepatic dysfunction:

        • Give 2 g of ticarcillin component every 24 hours
  • Intermittent hemodialysis (IHD) (administer after hemodialysis on dialysis days):

    • Dialyzable (20% to 50%):
      • 2 gms of ticarcillin component is given every 12 hours
      • It is supplemented with 3.1 g (ticarcillin/clavulanate) after each dialysis session.
      • Alternatively, give 2 g every 8 hours without a supplemental dose for deep-seated infections.
  • Dosing is dependent on the assumption of 3 times/week, complete IHD sessions.
  • Peritoneal dialysis (PD):

    • 1 g every 12 hours is given
  • Continuous renal replacement therapy (CRRT) :

    • Drug clearance is highly dependent on the method of renal replacement, type of filter, and flow rate.
    • Appropriate dosing needs close monitoring of pharmacologic response, signs of adverse reactions due to drug accumulation, and drug concentrations in relation to target trough (if appropriate).
    • The following are only general recommendations (based on dialysate flow/ultrafiltration rates of 1-2 L/hour and minimal residual renal function) and should not supersede clinical judgment:
      • CVVH:
        • a loading dose of 3.1g is given  followed by 2 g every 6-8 hours
      • CVVHD:
        • a loading dose of 3.1 g is given followed by 3.1 g every 6-8 hours
      • CVVHDF:
        • a loading dose of 3.1 g is given followed by 3.1 g every 6 hours
  • Do not give in intervals exceeding every 8 hours.
  • Clavulanate component is hepatically eliminated; which extends the dosing interval beyond 8 hours may result in loss of beta-lactamase inhibition.

Ticarcillin clavulanate dose in liver disease:

  • With concomitant renal dysfunction (Clcr<10 mL/minute): 2 g of ticarcillin component is given every 24 hours.

Side effects of Ticarcillin clavulanate

  • Cardiovascular:

    • Local Thrombophlebitis (With Iv Injection)
  • Central Nervous System:

    • Confusion
    • Drowsiness
    • Headache
    • Seizure
  • Dermatologic:

    • Skin Rash
  • Endocrine & Metabolic:

    • Electrolyte Disturbance
    • Hypernatremia
    • Hypokalemia
  • Gastrointestinal:

    • Clostridioides (Formerly Clostridium) Difficile-Diarrhea
    • Diarrhea
    • Nausea
  • Genitourinary:

    • Proteinuria (False Positive)
  • Hematologic & Oncologic:

    • Bleeding Complication
    • Eosinophilia
    • Hemolytic Anemia
    • Positive Direct Coombs' Test (False Positive)
  • Hepatic:

    • Hepatotoxicity
    • Increased Serum Alt
    • Increased Serum Ast
    • Jaundice
  • Immunologic:

    • Jarisch Herxheimer Reaction
  • Infection:

    • Fungal or bacterial Superinfection
  • Renal:

    • Acute Interstitial Nephritis
  • Miscellaneous:

    • Anaphylaxis

Contraindication to Ticarcillin clavulanate potassium Include:

  • Hypersensitivity is a history of severe reactions (eg anaphylaxis or Stevens-Johnson syndrome) to ticarcillin or clavulanate.

Warnings and precautions

  • Hypersensitivity reactions
    • Patients on penicillin therapy have experienced severe and sometimes fatal hypersensitivity reactions (anaphylactic)
    • This is especially true if they have a history beta-lactam hypersensitivity, sensitivity to multiple allergens or IgE-mediated reactions such as anaphylaxis, urticaria, or angioedema.
    • Asthmatic patients should be cautious.
  • Bleeding disorders:
    • Bleeding disorders are more common in patients with significant renal impairment.
    • If bleeding or thrombocytopenia occurs, stop immediately.
  • Hypokalemia
    • Hypokalemia has been observed
    • Monitor serum potassium for patients receiving prolonged therapy or who have a fluid or electrolyte imbalance.
  • Superinfection
    • Long-term use may lead to fungal or bacterial superinfection, including pseudomembranous colitis and C.difficile-associated diarrhoea (CDAD).
    • CDAD was seen after more than two months of postantibiotic treatment.
  • Heart failure (HF):
    • It could be challenging to use this medicine in HF patients due to high salt loading.
  • Renal impairment
    • Adjusting the dosage is advised for patients with compromised renal function.
  • Seizure disorders:
    • Patients with seizure disorders should be cautious. High levels of the drug, especially in the presence renal impairment, can increase the risk of seizures.

Monitor:

  • During the initial dose, watch for anaphylactic symptoms and signs;
  • serum electrolytes
  • bleeding time
  • periodic tests of renal, hepatic, and hematologic function

How to administer Ticarcillin clavulanate potassium?

Infuse intravenously over 30 minutes.

  •  If combination penicillin/aminoglycoside therapy is needed in a patient with renal dysfunction, separation of doses (if feasible), and routine monitoring of aminoglycoside levels, CBC, and clinical response should be done.

Mechanism of action of Ticarcillin clavulanate potassium:

  • A beta-lactam antibiotic, it prevents the formation of bacterial cell walls by attaching to one or more penicillin-binding proteins (PBPs)
  • It blocks the final step of peptidoglycan synthesis in bacterial cell walls.
  • Bacteria eventually lyse because of ongoing activity by cell wall autolytic enzymes (autolysins, murein hydrolases), while cell wall assembly becomes blocked.

Distribution:

  • Ticarcillin is mainly distributed into the tissue, interstitial fluid, pleural fluid, and bile;
  • low concentrations of ticarcillin distribute into the CSF but increase when meninges are inflamed.

Protein binding: Ticarcillin: almost 45%; Clavulanic acid: almost 25%

Metabolism: Clavulanic acid is metabolized via hepatic route

Half-life elimination:

  • Neonates: Ticarcillin: 4.4 hours & Clavulanic acid: 1.9 hours
  • Children (1 month to 9.3 years): Ticarcillin: 66 minutes & Clavulanic acid: 54 minutes

Adults:

  • Ticarcillin: 66 - 72 minutes; 13 hours (in patients having renal failure)
  • Clavulanic acid: 66 - 90 minutes; clavulanic acid does not affect the clearance of ticarcillin

Time to peak, plasma:

  • Immediately after completion of a 30-minute infusion

Excretion:

  • Children:
    • Ticarcillin: Via Urine (71% 50% as unchanged drug over 4 hours);
    • Clavulanic acid: Via Urine (50% as unchanged drug over 4 hours)
  • Adults:  
    • Ticarcillin: Via Urine (60% to 70% as unchanged drug);
    • Clavulanic acid: Via Urine (35% to 45% as unchanged drug)

International Brands of Ticarcillin clavulanate potassium:

  • Betabactyl
  • Claventin
  • Ticarcin
  • Ticarnic
  • Timentin

Ticarcillin clavulanate potassium brands in Pakistan:

Ticaclav (Inf: 3.2 gms: 4 vials - Rs.2040) -

Stallion